An essential role for nuclear factor κB in promoting double positive thymocyte apoptosis

Journal of Experimental Medicine

Volumn 189, Issue 1, 1999, Pages 145-157

  Hettmann, Thore ^a   DiDonato, Joseph ^b   Karin, Michael ^b   Leiden, Jeffrey M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; bcl x(L); Inhibitor B (A32 36); Nuclear factor KB; Thymocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 3; PROTEIN BCL X; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CYTOKINE PRODUCTION; ELECTROPHORETIC MOBILITY; EMBRYO; FETUS; GENE; GENE EXPRESSION; IMMUNOBLOTTING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIGENS, CD; APOPTOSIS; BCL-X PROTEIN; CELL DIVISION; CYTOKINES; DNA-BINDING PROTEINS; DOWN-REGULATION; ENHANCER ELEMENTS (GENETICS); FLOW CYTOMETRY; I-KAPPA B PROTEINS; INTERLEUKINS; MICE; MICE, TRANSGENIC; MITOGENS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033521663     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.1.145     Document Type: Article

References (94)

1. Grilli, M., J.J.-S. Chiu, and M.J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
2. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141-179.
3. Baldwin, A.S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
4. Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
5. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell. Biol. 10:405-455.
6. Kunsch, C., S. Ruben, and C. Rosen. 1992. Selection of optimal κB-Rel DNA-binding motifs: interaction of both sub-units of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
7. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
8. Beg, A.A., T.S. Finco, P.V. Nantermet, and A.S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell. Biol. 13:3301-3310.
9. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. USA. 90:2532-2536.
10. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. BenNeriah, and P.A. Baeuerle. 1993. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature. 365:182-185.
11. Thompson, J., R. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:573-582.
12. Alkalay, I., A. Yaron, A. Hatzubai, S. Jung, A. Avraham, O. Gerlitz, L. Pashut-Lavon, and Y. Ben-Neriah. 1995. In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol. Cell. Biol. 15:1294-1301.
13. DiDonato, J.A., F. Mercuric, and M. Karin. 1995. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol. Cell. Biol. 15:1302-1311.
14. Lin, Y.C., K. Brown, and U. Siebenlist. 1995. Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. Proc. Natl. Acad. Sci. USA. 92:552-556.
15. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science. 267: 1485-1488.
16. Traenckner, E.B., H.L. Pahl, T. Henkel, K.N. Schmidt, S. Wilk, and P.A. Baeuerle. 1995. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO (Eur. Mol. Biol. Organ.) J. 14:2876-2883.
17. Scherer, D.C., J.A. Brockman, Z. Chen, T. Maniatis, and D.W. Ballard. 1995. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA. 92:11259-11263.
18. Chen, Z., J. Hagler, V.J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
19. Sen, J., L. Venkataraman, Y. Shinkai, J.W. Pierce, F.W. Alt, S.J. Burakoff, and R. Sen. 1995. Expression and induction of nuclear factor-kappa B-related proteins in thymocytes. J. Immunol. 154:3213-3221.
20. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. Oncogene. 9:3289-3297.
21. Feuillard, J., C. Dargemont, V. Ferreira, N. Tarantino, P. Debre, M. Raphael, and M. Korner. 1997. Nuclear Rel-A and c-Rel protein complexes are differentially distributed within human thymocytes. J. Immunol. 158:2585-2591.
22. Chen, D., and E.V. Rothenberg. 1993. Molcular basis for developmental changes in Interleukin-2 gene inducibility. Mol. Cell. Biol. 13:228-237.
23. + T-lymphocytes. Science. 256:1452-1456.
24. Sha, W.C., H.C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 80: 321-330.
25. Snapper, C.M., P. Zelazowski, F.R. Rosas, M.R. Kehry, M. Tian, D. Baltimore, and W.C. Sha. 1996. B cells from p50/ NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156:183-191.
26. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:531-536.
27. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multi-organ inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell. 80:331-340.
28. -/- double knockout mice. J. Exp. Med. 185:1359-1370.
29. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
30. Doi, T.S., T. Takahashi, O. Tagushi, T. Azuma, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative response. J. Exp. Med. 185:953-961.
31. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:167-170.
32. Horwitz, B.H., M.L. Scott, S.R. Cherry, R.T. Bronson, and D. Baltimore. 1997. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity. 6:765-772.
33. Boothby, M.R., A.L. Mora, D.C. Scherer, J.A. Brockman, and D.W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB. J. Exp. Med. 185:1897-1907.
34. Arsura, M., M. Wu, and G.E. Sonnenshein. 1996. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκBα. Immunity. 5:31-40.
35. Wu, M., M. Arsura, R.E. Bellas, M.J. FitzGerald, H. Lee, S. Schauer, D.H. Sherr, and G.E. Sonnenshein. 1996. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol. Cell. Biol. 16:5015-5025.
36. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274: 782-784.
37. Van Antwerp, D., S. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-a-induced apoptosis by NF-κB. Science. 274:787-789.
38. Wang, C.-Y., M.W. Mayo, and A.S. Baldwin. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:784-786.
39. Liu, Z.-g., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:565-576.
40. Grimm, S., M.K. Bauer, P.A. Baeuerle, and K. Schulze-Osthoff. 1996. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell Biol. 134:13-23.
41. Jung, M., Y. Zhang, S. Lee, and A. Dritschilo. 1995. Correction of radiation sensitivity in ataxia telangiectasia by a truncated IκB-α. Science. 268:1619-1621.
42. Bessho, R., K. Matsubara, M. Kubot, K. Kuwakado, H. Hirota, Y. Wakazono, Y. Wei Lin, A. Okuda, M. Kawai, R. Nishikomoro, and T. Heike. 1994. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Phamacol. 48:1883-1889.
43. Grilli, M., M. Pizzi, M. Memo, and P.F. Spano. 1996. Neuroproduction by aspirin and sodium salicylate through blockade by NF-κB activation. Science. 274:1383-1385.
44. Ivanov, V.N., R.K. Lee, E.R. Podack, and T.R. Malek. 1997. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-κB. Oncogens. 14:2455-2464.
45. Abbadie, C., N. Kabrun, F. Bouali, J. Smardova, D. Stehelin, B. Banderbunder, and P.J. Enrietto. 1993. High level of c-Rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell. 75:899-912.
46. Esslinger, C.W., A. Wilson, B. Sordat, F. Beermann, and C.V. Jongeneel. 1997. Abnormal T cell development induced by targeted overexpression of IκBα. J. Immunol. 158: 5075-5078.
47. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
48. Lake, R.A., D. Wotton, and M.J. Owen. 1990. A 3′ transcriptional enhancer regulates tissue-specific expression of the human CD2 gene. EMBO (Eur. Mol. Biol. Organ.) J. 9:3129-3136.
49. Wang, C.-Y., A.G. Bassuk, L.H. Boise, C.B. Thompson, R. Bravo, and J.M. Leiden. 1994. Activation of the granulocytemacrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Mol. Cell. Biol. 14:1153-1159.
50. Ballard, D.W., W.H. Walker, S. Doerre, P. Sista, J.A. Molitor, E.P. Dixon, N.J. Peffer, M. Hannink, and W.C. Greene. 1990. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function. Cell. 63:803-814.
51. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
52. Finco, T.S., and A.S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 3:263-272.
53. Lang, G., D. Wotton, M.J. Owen, W.A. Sewell, M.H. Brown, D.Y. Mason, M.J. Crumpton, and D. Kioussis. 1988. The structure of the human CD2 gene and its expression in transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 7:1675-1682.
54. Owen, M.J., E.J. Jenkinson, M.H. Brown, W.A. Sewell, G.W. Krissansen, M.J. Crumpton, and J.J. Owen. 1988. Murine CD2 gene expression during fetal thymus ontogeny. Eur. J. Immunol. 18:187-189.
55. Kolodziej, P.A., and R.A. Young. 1991. Epitope tagging and protein surveillance. Methods Enzymol. 194:508-516.
56. Moore, N.C., J. Girdlestone, G. Anderson, J.T. Owen, and E.J. Jenkinson. 1995. Stimulation of thymocytes before and after positive selection results in the induction of different NF-κB/Rel protein complexes. J. Immunol. 155:4653-4660.
57. Nolan, G.P., T. Fujita, K. Bhatia, C. Huppi, H.C. Liou, M.L. Scott, and D. Baltimore. 1993. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13:3557-3566.
58. Plaksin, D., P.A. Baeuerle, and L. Eisenbach. 1993. κBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2κB gene expression in metastatic tumor cells. J. Exp. Med. 177: 1651-1662.
59. Verweij, C.L., M. Geerts, and L.A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element J. Biol. Chem. 266:14179-14182.
60. Crabtree, G.R., and N.A. Clipstone. 1994. Signal transmission between the plasma mambrane and nucleus of T-lymphocytes. Annu. Rev. Biochem. 63:1045-1083.
61. Shi, Y., R.P. Bissonnette, N. Parfrey, M. Szalay, R.T. Kubo, and D.R. Green. 1991. In vivo administration of mononuclear antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J. Immunol. 146:3340-3346.
62. + thymocytes in the absence of clonotypic T cell antigen receptor. Eur. J. Immunol. 26:1012-1017.
63. Smith, C.A., A.G.T. Williams, R. Kingston, E.J. Jenkinson, and J.J.T. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 337:181-184.
64. Lowe, S.W., E.M. Schmitt, S.W. Smith, B. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:847-849.
65. Chao, D.T., and S.J. Korsmeyer. 1998. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16:395-419.
66. Gratiot-Deans, J., L. Ding, L.A. Turka, and G. Nunez. 1993. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic activation. J. Immunol. 151: 83-91.
67. Veis, D.J., C.L. Sentman, E.A. Bach, and S.J. Korsmeyer. 1993. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151:2546-2554.
68. Ma, A., J.C. Pena, B. Chang, E. Margosian, L. Davidson, F.W. Alt, and C.B. Thompson. 1995. Bcl-x regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA. 92:4763-4767.
69. L displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice J. Exp. Med. 182:1973-1983.
70. L and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182:821-828.
71. Durand, D.B., J.-P. Shaw, M.R. Bush, R.E. Replogle, R. Belagave, and G.R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1720.
72. Ballard, D.W., E. Bohnlein, M. Siekevitz, and W.C. Greene. 1989. κB-specific DNA binding proteins: a role in the regulation of human interleukin-2 gene expression. Science. 244: 457-459.
73. Serfling, E., A. Avots, and M. Neumann. 1995. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activtion. Biochem. Biophys. Acta. 1263:181-200.
74. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the interleukin 2 gene. Curr. Opin. Immunol. 7:333-342.
75. Shaw, J.P., P.J. Utz, D.B. Durand, J.J. Toole, E.A. Emmel, and G.R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science. 241:202-205.
76. Jain, J., Z. Miner, and A. Rao. 1993. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J. Immunol. 151:837-848.
77. Hodge, M.R., A.M. Ranger, F.C. de la Brousse, T. Hoey, M. Grusby, and L.H. Glimcher. 1996. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity. 4:397-405.
78. Xanthoudakis, S., J.P.B. Viola, K.T.Y. Shaw, C. Luo, J.D. Wallace, P.D. Bozza, D.C. Luk, T. Curran, and A. Rao. 1996. An enhanced immune response in mice lacking the transcription factor NFAT1. Science. 272:892-895.
79. Lai, J.H., and T.H. Tan. 1994. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 269:30077-30080.
80. Bryan, R.G., Y. Li, J.H. Lai, M. Van, N.R. Rice, R.R. Rich, and T.H. Tan. 1994. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell. Biol. 14:7933-7942.
81. Ghosh, P., T.H. Tan, N.R. Rice, A. Sica, and H.A. Young. 1993. The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA. 90:1696-1700.
82. Lindsten, T., C.H. June, J.A. Ledbetter, G. Stella, and C.B. Thompson. 1998. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science. 244:339-343.
83. Tanchot, C., F.A. Lemonnier, B. Perarnau, A.A. Freitas, and B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science. 276: 2057-2062.
84. Osborne, B.A. 1996. Apoptosis and maintenance of homeostasis in the immune system. Curr. Opin. Immunol. 8:245-254.
85. Allen, P.M. 1994. Peptides in negative and positive selection: a delicate balance. Cell. 76:593-596.
86. Nossal, G.J.V. 1994. Negative selection of lymphocytes. Cell. 76:229-232.
87. Baeuerle, P.A., and D. Baltimore. 1996. NF-κB: ten years after. Cell. 87:13-20.
88. Jenkinson, E.J., R. Kingston, E.J. Jenkinson, and J.J.T. Owen. 1989. Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell repertoire. Eur. J. Immunol. 19:2175-2181.
89. Wyllie, A.H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:555-557.
90. Cohen, J.J., and R.C. Duke. 1984. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 123:38-45.
91. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:849-852.
92. Yang, X.-F., G.F. Weber and H. Cantor. 1997. A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity. 7:629-639.
93. Lenardo, M.J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature. 353:858-891.
94. Haskill, S., A.A. Beg, S.M. Tompkins, J.S. Morris, A.D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A.S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell. 65:1281-1289.